Major investor on ALK: Pipeline is lacking
Allergy company ALK lacks new development projects to ensure future growth, according to the company’s major shareholder ATP, online media Finans reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.